Article
Inhibitory effect of troleandomycin on the metabolism of omeprazole is CYP2C19 genotype-dependent.
Xenobiotica; the fate of foreign compounds in biological systems - 1 Feb 2003
He Nan, Huang Song-Lin, Zhu Rong-Hua, Tan Zhi-Rong, Liu Jie, Zhu Bing, Zhou Hong-Hao
Abstract excerpt
1. Eighteen healthy CYP2C19 genotyped male subjects were administered a 20-mg oral dose of omeprazole (OP) alone or received troleandomycin (TAO) 500 mg daily for 2 days before the dose of OP was administered. Blood samples were obtained and OP 5-hydroxyomeprazole (5-OH-OP) and OP sulfone in plasma were determined by reversed-phase HPLC. 2. The mean C(max), AUC and CL for OP in poor metabolizers (PMs) were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
